Firm
King & Spalding has now hired 15 partners from Winston Taylor and legacy firm Winston & Strawn in offices spanning Texas, San Francisco, and Chicago
Firm says its work with a biotech client could signal a sea change in how - and when - law firms enter the drug development process
In an exclusive interview, Bernard Ledeboer reveals how a Consolid-backed group of firms wants to expand across Europe, invest in AI and centralise operations to compete at the top tier
Laura Achával, founder of Achával IP in Argentina, shares how an evolving vision led her to launch her own practice
Sponsored
Sponsored
-
Sponsored by Licks AttorneysEduardo Hallak, Rafaella Oliveira, and Laís Souza of Licks Attorneys explain how the provision operates in practice, highlighting evidential hurdles and best practices for patent applicants -
Sponsored by Liu, Shen & AssociatesChunyu Cui and Ziqing Wu of Liu, Shen & Associates say recent trends in China’s intellectual property courts indicate alignment with international standards and send a clear signal to the global market
-
Sponsored by Cabinet M OproiuRaluca Vasilescu of Cabinet M Oproiu considers how the use of AI assistants may influence clients’ general expectations regarding patent attorneys’ work
-
Sponsored by Chang Tsi & PartnersRyan (Liangrui) Xu of Chang Tsi & Partners summarises key examination hurdles, landmark cases, and strategic opportunities for patent applicants using parameter-defined claims in China
-
Sponsored by Wanhuida Intellectual PropertyRevised examination guidelines and evolving technology have driven a surge in smart medicine patent filings and grants. Jie Zhao of Wanhuida Intellectual Property examines several examples of significance for foreign applicants
-
Sponsored by Berken IPEmilio Berkenwald of Berken IP says that although the move potentially eases prosecution, several issues – particularly concerning second medical use claims – remain
